Follicum collaborates with proDERM for the upcoming Phase IIa clinical trial on patients with hair loss
Follicum appoints new CEO and establishes new role as Chief Scientific Officer
Clinical progress of Follicum's lead candidate FOL-005 for hair growth presented at the world's largest hair conference
Endpoints News article about Follicum
Follicum takes a step closer to phase III entering 2021 - BioStock
What Hair Loss Treatments Could Look Like in the Future | Allure
Female alopecia – new solutions on the horizon - BioStock
Follicum AB on schedule to present top-line results from the phase IIa study with FOL-005 for hair growth at the end of October
Is the Age-Old Quest for a Baldness Cure Reaching Its End? | The New Yorker
Follicum applies for extended patent for its topical formulation - BioStock
Follicum strengthens its clinical expertise in diabetes as novel peptide candidate approaches clinic - establishes Scientific Ad
Follicum (FOLLI) aktie | Videos - Börskollen
Market notice 189/21 – Follicum is moved to the Observation List
Follicum finalises patient recruitment in hair growth study - BioStock
211108 - Information från Follicums extra bolagsstämma
Follicum applies for extended patent for its topical formulation - BioStock
Follicum comments on patent notice for diabetes candidate - BioStock
Follicum receives European patent for the company's peptides for developing first in class diabetes treatments
World TB Day: Iconovo's ICOone platform in the spotlight - BioStock
150/19 – Information regarding the rights issue from Follicum AB
